Aurinia Pharmaceuticals Inc (AUPH)

[Whalatane]

Micham. You are / were a practicing attorney … correct ?
And you think AUPH has shared the AURORA -2 data already , to whom they deem interested BP’s under Non Disclosure Agreements ?
And Co faces no legal jeopardy in doing so ?
Safest thing for AUPH is to announce / publish this trials results all at once to all .
Top line data first followed by details in a publication like the NEJM / Lancet if necessary

There are signals from an earlier trial that Voclosporin may slightly improve eGFR …which would be huge as these patients are expected to have declining kidney function over time
This trial will also , I think ,have the longest safety data of any drug used for LN
They won’t rush the analysis and will chk and rechk their data , slice and dice it ( who benefits most and why ) before publishing / sharing
JMO
Kiwi